Alaunos Therapeutics | ZIOP - Sales Revenues


Alaunos Therapeutics reported $2K in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Amgen USD 9.9B 340M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Biogen USD 2.28B 250M Dec/2025
Bioline Rx USD 427K 123K Sep/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Celltrion KRW 1.33T 0 Mar/2026
Corcept Therapeutics USD 202.12M 5.48M Dec/2025
Cspc Pharmaceutical CNY 6.11B 502.75M Dec/2025
Curis USD 1.14M 1.41M Dec/2025
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Gilead Sciences USD 7.93B 130M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Incyte USD 1.27B 240M Mar/2026
Intrexon USD 717K 511K Jun/2024
Ionis Pharmaceuticals USD 203M 46M Dec/2025
J&J USD 24.1B 500M Mar/2026
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Karyopharm Therapeutics USD 34.08M 3.54M Dec/2025
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Medical Developments International AUD 21.57M 12.04M Dec/2025
Merck USD 16.4B 880M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Novartis USD 13.11B 226M Mar/2026
Organigram Holdings CAD 63.54M 16.52M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
Pharma Mar EUR 90.2M 54.5M Dec/2025
PTC Therapeutics USD 164.7M 46.3M Dec/2025
Qiagen NV USD 419.22M 38.16M Mar/2026
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sangamo BioSciences USD 356K 125K Jun/2024
Sartorius EUR 899.1M 28.5M Mar/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
TG Therapeutics USD 192.57M 30.87M Dec/2025
Tilray USD 217.51M 74.75M Dec/2025
Verastem USD 17.54M 7.53M Dec/2025
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025